QuidelOrtho Corporation (QDEL) earnings

QDEL earnings moved a median of +0.07% by the close. Quarterly and annual QDEL reports and results, each read against the price at its own news timestamp. Back to the QDEL overview →

31 measured QDEL earnings events.

Where these QDEL earnings landedvs 31 measured QDEL earnings reactions
QDEL earningsMiddle 50% · -3.14% to +2.00%Zero: 0.00%Median: +0.07%Median +0.07%-4.00%0+4.00%
Middle 50% of QDEL earnings reactions-3.14% to +2.00%
Median reaction (to close)+0.07%
Measured reactions31
Point-in-time · zero look-ahead

Half of the 31 QDEL earnings events with a measured close landed between -3.14% and +2.00%; 52% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q QuidelOrtho Corp For: Jun 28SEC filing · Form 10-Q-4.46%-3.04%
QuidelOrtho Reports Second Quarter 2026 Financial ResultsPress release-4.46%-3.04%
QuidelOrtho to Report Second Quarter 2026 Financial ResultsPress release-2.03%-4.29%
Form 10-Q QuidelOrtho Corp For: Mar 29SEC filing · Form 10-Q-1.66%-1.79%
QuidelOrtho Reports First Quarter 2026 Financial ResultsPress release-1.66%-1.79%
QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 GuidancePress release-1.86%-7.41%
Form 10-K QuidelOrtho Corp For: Dec 28SEC filing · Form 10-K-0.43%-3.24%
Form 10-Q QuidelOrtho Corp For: Sep 28SEC filing · Form 10-Q-5.95%-19.71%
QuidelOrtho Reports Third Quarter 2025 Financial ResultsPress release-5.95%-19.71%
QuidelOrtho to Report Third Quarter 2025 Financial ResultsPress release+0.43%-0.60%
Form 10-Q QuidelOrtho Corp For: Jun 29SEC filing · Form 10-Q-3.28%-14.01%
QuidelOrtho Reports Second Quarter 2025 Financial ResultsPress release-3.28%-14.01%
QuidelOrtho to Report Second Quarter 2025 Financial ResultsPress release+0.67%+1.72%
Form 10-Q QuidelOrtho Corp For: Mar 30SEC filing · Form 10-Q+8.90%+27.22%
QuidelOrtho Reports First Quarter 2025 Financial ResultsPress release+8.90%+27.22%
QuidelOrtho to Report First Quarter 2025 Financial ResultsPress release-1.08%+6.80%
Form 10-K QuidelOrtho Corp For: Dec 29SEC filing · Form 10-K+0.31%+1.16%
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024Press release-3.23%-2.58%
Form 10-Q QuidelOrtho Corp For: Sep 29SEC filing · Form 10-Q+5.63%+4.74%
QuidelOrtho Reports Third Quarter 2024 Financial ResultsPress release+5.63%+4.74%
QuidelOrtho to Report Third Quarter 2024 Financial ResultsPress release+0.16%+0.07%
Form 10-K/A QuidelOrtho Corp For: Dec 31SEC filing · Form 10-K-2.50%+0.38%
Form 10-Q QuidelOrtho Corp For: Jun 30SEC filing · Form 10-Q+0.28%+0.53%
QuidelOrtho Reports Second Quarter 2024 Financial ResultsPress release-2.50%+0.38%
QuidelOrtho to Report Second Quarter 2024 Financial ResultsPress release+1.29%+2.41%
Form 10-Q QuidelOrtho Corp For: Mar 31SEC filing · Form 10-Q+2.44%+2.27%
QuidelOrtho Reports First Quarter 2024 Financial ResultsPress release+2.44%+2.27%
QuidelOrtho To Report First Quarter 2024 Financial ResultsPress release-0.77%-4.06%
Form 10-K QuidelOrtho Corp For: Dec 31SEC filing · Form 10-K-0.07%-0.16%
Form 10-Q QuidelOrtho Corp For: Oct 01SEC filing · Form 10-Q+1.37%+1.05%
QuidelOrtho Reports Third Quarter 2023 Financial ResultsPress release+1.37%+1.05%
That’s how QDEL usually reacts to earnings — get an email when it moves on news →
Keep exploring

More QDEL: analyst actions → · SEC filings → · QDEL overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
PDL BIOPHARMA (PDLI)9670.00%46%
Ultragenyx Pharmaceutical Inc. (RARE)967+0.12%56%
Recro Pharma, Inc. (REPH)9650.00%43%
Athenex, Inc. (ATNX)964-0.43%41%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.